Neuropilin 1 anticorps (PE)
-
- Antigène Voir toutes Neuropilin 1 (NRP1) Anticorps
- Neuropilin 1 (NRP1)
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp Neuropilin 1 est conjugé à/à la PE
-
Application
- Intracellular Flow Cytometry (ICFC)
- Purification
- The antibody was purified by affinity chromatography and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.
- Clone
- 12C2
- Isotype
- IgG2a kappa
- Top Product
- Discover our top product NRP1 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Buffer
- Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Protect from prolonged exposure to light. Do not freeze.
- Stock
- 4 °C
- Stockage commentaire
- The antibody solution should be stored undiluted between 2°C and 8°C.
-
- Antigène
- Neuropilin 1 (NRP1)
- Autre désignation
- CD304 (NRP1 Produits)
- Synonymes
- anticorps NRP1, anticorps cd304, anticorps neuropilin, anticorps np-1, anticorps npn-1, anticorps nrp, anticorps nrp-1, anticorps vegf165r, anticorps BDCA4, anticorps CD304, anticorps NP1, anticorps NRP, anticorps VEGF165R, anticorps C530029I03, anticorps NP-1, anticorps NPN-1, anticorps Npn1, anticorps Nrp, anticorps neuropilin 1, anticorps neuropilin 1 L homeolog, anticorps NRP1, anticorps nrp1, anticorps Nrp1, anticorps nrp1.L
- Sujet
- CD304, also known as neuropilin-1, BDCA-4 and VEGF165R, is a 140 kD type I transmembrane protein. Its extracellular region contains 2 CUB, 2 FV/FVIII, and one MAM domain, a soluble isoform is produced by alternative mRNA splicing. CD304 is involved in angiogenesis, neural development, and tumor metastasis. It's expressed by plasmacytoid dendritic cells, thymocytes, neurons, endothelium, and a subset of TFH cells. CD304 is also expressed in several carcinomas, and a high expression of this molecule in prostate cancer correlates with a poor prognosis.
- Pathways
- Regulation of Cell Size, Signaling Events mediated by VEGFR1 and VEGFR2, Smooth Muscle Cell Migration, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals
-